Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02252159 · ClinicalTrials.gov registry record
Prospective Observational Study Of Patients With Polycythemia Vera In US Clinical Practices (REVEAL)
A clinical trial, sponsored by Incyte Corporation.
- Completed
- Registry status
- 2,544
- Enrollment target
NCT02252159 is a clinical trial that has completed, run by Incyte Corporation. The registered enrollment target is 2,544 participants.
The verdict
NCT02252159 has completed, sponsored by Incyte Corporation.
- COMPLETED
- Registry status
- 2,544 participants
- Enrollment target
Study Summary
This is a Phase IV, multicenter, non-interventional, non-randomized, prospective, observational study in an adult population (patients \>18 years old) of men and women who have been diagnosed with clinically overt PV and are being followed in either community or academic medical centers in the United States who will be enrolled over a 12-month period and observed for 36 months from the date the last patient is enrolled.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,544 participants |
| Start Date | 2014-07-31 |
| Est. Completion | 2019-08-03 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02252159
The ClinicalTrials.gov registry entry for NCT02252159 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 2,544 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Incyte Corporation, which has 239 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT02252159 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02252159 about?
NCT02252159 is a clinical study titled "Prospective Observational Study Of Patients With Polycythemia Vera In US Clinical Practices (REVEAL)". This is a Phase IV, multicenter, non-interventional, non-randomized, prospective, observational study in an adult population (patients \>18 years old) of men and women who have been diagnosed with clinically overt PV and are being followed in either community or academic medical centers in the Unite...
What is the current status of trial NCT02252159?
This trial is currently completed. The enrollment target is 2,544 participants. The study started on 2014-07-31. Estimated completion is 2019-08-03.
Who is sponsoring clinical trial NCT02252159?
This trial is sponsored by Incyte Corporation, which has 239 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.